CBSA creates
co-opportunity
for the Colorado
life sciences
community.

Share COVID-19 supplies and contribute your expertise in our CO Life Sciences Connection Center.
Visit our COVID-19 resource guide.

Learn More
Life Sciences Impact Capital + Growth Policy + Advocacy

Colorado BioScience Institute

Our workforce cultivation activities build knowledge, skills and leadership capabilities.

Learn More

Why Colorado

Our robust economy, collaborative culture, leading academic and research institutions, pro-innovation business climate, and excellent quality of life make Colorado a leading choice to start, scale or relocate a life sciences business.

Learn More

Networking + Events

CBSACommunity
More
19
Wednesday, Aug 19, 2020
3:00—4:30pm

Next Event

All Member Meeting 2020

19
Wednesday, Aug 19, 2020
3:00—4:30pm
Join CBSA virtually to engage around the previous year's work and discuss what is to come! Complimentary to CBSA members in good standing.
Learn More
12
Wednesday, Aug 12, 2020 —
Thursday, Aug 13, 2020

Next Event

RVC’s Colorado Capital Conference 2020

12
Wednesday, Aug 12, 2020 —
Thursday, Aug 13, 2020
Learn More

Stay up to date with one of the country’s most dynamic life sciences ecosystems. Subscribe to the CBSA newsletter today.

Subscribe

News + Blog

CBSA NewsEcosystem NewsUncategorized
More

Weekly Policy Update: CBSA Advocates for Additional Relief for Life Sciences Startups + Growth Companies

Learn More

Weekly Policy Update: CBSA Meets with Congressional Offices on the VALID Act

Learn More

ClinImmune Labs Change Patient Outcomes in Unique Ecosystem

Learn More

Weekly Policy Update: Energize Colorado Gap Fund Launches August 2020

Learn More

Weekly Policy Update: Federal Lawmakers Introduce Diagnostic Testing Bills

Learn More

Colorado-based New Iridium accelerating global production of potential COVID-19 treatment using light-driven chemistry

Learn More

KromaTiD Announces Launch of New Product, dGH In-Site™

Learn More

Boulder Biotech Company to be Acquired for $1.4B

Learn More

Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering

Learn More

Edgewise Therapeutics Appoints Kirsten L. Gruis, M.D., M.S. as Chief Medical Officer

Learn More

Sana Health raises $5.8M to get through clinical trials

Learn More

Industry Experts Update State Policymakers on COVID-19 Efforts

Learn More